Core Laboratories (NYSE:CLB – Get Free Report) updated its first quarter 2026 earnings guidance on Thursday. The company provided EPS guidance of 0.050-0.070 for the period, compared to the consensus EPS estimate of 0.160. The company issued revenue guidance of $119.0 million-$123.0 million, compared to the consensus revenue estimate of $127.2 million.
Analyst Upgrades and Downgrades
Separately, Weiss Ratings reissued a “hold (c)” rating on shares of Core Laboratories in a research note on Friday, March 27th. Four analysts have rated the stock with a Hold rating, According to data from MarketBeat, the company has an average rating of “Hold” and a consensus price target of $12.50.
Check Out Our Latest Report on Core Laboratories
Core Laboratories Price Performance
Core Laboratories (NYSE:CLB – Get Free Report) last released its quarterly earnings data on Wednesday, February 4th. The oil and gas company reported $0.21 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.20 by $0.01. Core Laboratories had a return on equity of 12.18% and a net margin of 6.04%.The company had revenue of $138.26 million during the quarter, compared to the consensus estimate of $130.40 million. During the same quarter in the prior year, the firm posted $0.22 earnings per share. The firm’s revenue was up 7.0% compared to the same quarter last year. Core Laboratories has set its Q1 2026 guidance at 0.110-0.150 EPS. On average, research analysts anticipate that Core Laboratories will post 0.96 earnings per share for the current year.
Core Laboratories Announces Dividend
The business also recently disclosed a quarterly dividend, which was paid on Monday, March 9th. Stockholders of record on Monday, February 16th were paid a $0.01 dividend. The ex-dividend date was Friday, February 13th. This represents a $0.04 annualized dividend and a dividend yield of 0.2%. Core Laboratories’s payout ratio is currently 5.97%.
Institutional Investors Weigh In On Core Laboratories
Hedge funds have recently added to or reduced their stakes in the company. Aster Capital Management DIFC Ltd acquired a new stake in Core Laboratories in the fourth quarter valued at approximately $34,000. Quarry LP grew its stake in Core Laboratories by 118.1% in the third quarter. Quarry LP now owns 2,953 shares of the oil and gas company’s stock valued at $36,000 after acquiring an additional 1,599 shares during the period. Tower Research Capital LLC TRC grew its stake in Core Laboratories by 400.9% in the second quarter. Tower Research Capital LLC TRC now owns 7,333 shares of the oil and gas company’s stock valued at $84,000 after acquiring an additional 5,869 shares during the period. Vestcor Inc acquired a new stake in Core Laboratories in the third quarter valued at approximately $101,000. Finally, Mercer Global Advisors Inc. ADV bought a new position in Core Laboratories in the 3rd quarter valued at about $132,000. Institutional investors and hedge funds own 97.81% of the company’s stock.
About Core Laboratories
Core Laboratories N.V. is a global provider of proprietary and patented reservoir description and production enhancement services to the oil and gas industry. The company applies specialized expertise in core and fluid analysis, advanced petrophysical interpretation, and reservoir engineering to optimize hydrocarbon recovery. By integrating laboratory testing with field services and digital analytics, Core Laboratories delivers insights that help operators maximize production and extend the life of their assets.
The company’s portfolio spans two primary service lines: reservoir description and production enhancement.
Featured Stories
Receive News & Ratings for Core Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.
